Want to join the conversation?
Industrial engineering company $EMR posted lower 2Q16 net earnings of $369MM or $0.57 per diluted share vs. 2Q15. Adjusted EPS rose 2% to $0.66, excluding certain items. 2Q16 net sales fell 9%, with underlying sales down 5%, excluding unfavorable currency translation and an impact from divestitures of 2% each.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.